Endoscopic resection (endoscopic mucosal resection/ endoscopic submucosal dissection) for early gastric cancer.
Endoscopic resection of early gastric cancer is a well-established standard therapy in Japan and Korea, and is increasingly used in other countries. Endoscopic resection should be curative for patients, and safe, easy and effective not only for patients, but also for endoscopists. Endoscopic submucosal dissection (ESD) is superior to standard endoscopic mucosal resection (EMR) as it is designed to provide en bloc R0 resection regardless of size and/or location. Correct pathological assessment of en bloc resected specimens is crucial for accurate diagnosis and patient stratification for the risk of metastasis. Outcome studies in Japan and Korea, countries with the highest incidence of gastric cancer, have shown that ESD is efficacious in leading to a good long-term outcome; however, ESD requires an experienced endoscopist with a high skill level. Expanded indications for endoscopic resection have been proposed, especially after large en bloc resection have been accomplished using ESD. The use of ESD could be of huge benefit for the management of gastrointestinal superficial neoplasms. However, for ESD to become a viable therapeutic option, it requires close and supportive working relationships between endoscopists, pathologists and surgeons.
Department of Gastroenterology and Hepatology, Tokyo Medical University Hospital, Tokyo, Japan. takujigotoda@yahoo.co.jp
Takuji
T
Gotoda
Hwoon-Yong
HY
Jung
D000230:Adenocarcinoma / Q000473:pathology* / Q000601:surgery*; D000231:Adenocarcinoma, Papillary / Q000473:pathology* / Q000601:surgery*; D018450:Disease Progression; D004210:Dissection / Q000295:instrumentation / Q000379:methods*; D004867:Equipment Design; D005500:Follow-Up Studies; D005753:Gastric Mucosa / Q000473:pathology* / Q000601:surgery*; D005773:Gastroscopy / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D007564:Japan; D008207:Lymphatic Metastasis / Q000473:pathology; D008403:Mass Screening / Q000379:methods; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011230:Precancerous Conditions / Q000473:pathology* / Q000601:surgery*; D011379:Prognosis; D056910:Republic of Korea; D013274:Stomach Neoplasms / Q000473:pathology* / Q000601:surgery*; D016896:Treatment Outcome